NASA could be sending a crew on the Orion spacecraft out past the moon in less than a month if everything falls into place. But first the agency has to get its rocket to the launch pad. That could ...

Launch could come as soon as Feb. 6. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. The first crewed moon mission in more than 50 years remains ...

Jason Statham fans have yet another title to enjoy on streaming. However, the news is also extremely frustrating. Tubi welcomed back the high-octane Transporter 3 on Jan. 1, 2026. While that is great ...

For individuals with advanced chronic kidney disease (CKD), angiotensin-converting enzyme inhibitor (ACEi) or angiotensin-receptor blocker (ARB) treatment is associated with a reduced risk for kidney ...

The U.S. Food and Drug Administration has issued an alert for “a potentially high-risk issue” regarding two glucose monitor sensors that have been malfunctioning and linked to multiple fatalities. The ...

SpaceX launched 140 commercial payloads to Sun-synchronous orbit on its sixth rideshare mission of the year, Transporter-15. The Falcon 9 lifted off from Vandenberg Space Force Base’s Space Launch ...

Please provide your email address to receive an email when new articles are posted on . Dulaglutide, semaglutide and tirzepatide had similar GI safety profiles. An increased risk for GI adverse events ...

About The Study: Within the studied participants, there were clear absolute benefits of sodium-glucose cotransporter 2 (SGLT2) inhibitors on kidney, hospitalization, and mortality outcomes ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Intestinal models have been studied extensively using in vitro microfluidic platforms, ...

Walmart will become the first U.S. retailer to sell Abbott’s continuous glucose monitoring device as the medtech giant looks to broaden its sales potential for its growing business unit. Abbott has ...

The sodium-glucose cotransporter (SGLT)2 inhibitor empagliflozin (EMPA) is a hypoglycemic drug for patients with type 2 diabetes mellitus and cardiovascular disease. The mechanisms underlying the ...